Although NE is present in the intestinal lumen 24 , it is not clear whether NE in the intestinal tissue is released into the intestinal lumen and there appear to be no reports of NE-mediated increases in E
In the large intestine GLP-1 gets produced and that GLP-1 will improve the health of the pancreas, insulin secretion, insulin biosynthesis, help beta cells, help decrease the output of glucose from the liver, and the GLP-1 helps with muscular and adipose tissue insulin sensitivity and stomach emptying
The interplay between GIP and GLP-1 creates synergistic effects that neither pathway achieves alone, which is why tirzepatide results exceeded those of semaglutide in head-to-head comparisons
If you stop taking your blood pressure medicine, what do you think happens? Dr
Frias et al
GLP-1 medications are to be injected into fatty tissue like the upper thigh, arm or stomach, where there's typically an adequate fat layer